英格兰转移性皮肤鳞状细胞癌的全国发病率
该全国性人群研究基于英格兰国家癌症登记与分析服务(NCRAS)数据,纳入2013年至2015年76977例首次原发性皮肤鳞状细胞癌(cSCC)患者,分析其转移性cSCC(mcSCC)的发病率及危险因素。结果显示男性年龄标化发病率为77.3/10万人年,女性为34.1/10万人年;随访最长36个月,女性mcSCC累积发病率为1.1%,男性为2.4%。
要点
- 2013至2015年英格兰首次原发性cSCC年龄标化发病率男性77.3/10万人年,女性34.1/10万人年。
- 随访最长36个月,原发性cSCC患者中mcSCC累积发病率女性1.1%,男性2.4%。
- 高龄、男性、免疫抑制、更高贫困五分位、耳部及唇部原发肿瘤与转移风险升高相关。
核心结论
- 本研究首次报告英格兰mcSCC的全国发病率,为未来医疗规划、识别高危患者及评估皮肤癌预防政策提供流行病学数据。
研究设计与样本
- 全国性人群研究,基于英格兰NCRAS病理报告诊断代码识别2013年1月1日至2015年12月31日cSCC及mcSCC患者队列,数据分析时间为2017年3月1日至2018年3月1日。
主要发现
- 2013至2015年共76977例首次原发性cSCC患者,男性占62.7%,中位年龄80岁(四分位距72-86岁)。
- 首次登记cSCC的年龄标化发病率男性为77.3/10万人年(95%CI 76.6-78.0),女性为34.1/10万人年(95%CI 33.7-34.5)。
- 随访最长36个月,原发性cSCC患者中mcSCC累积发病率女性为1.1%,男性为2.4%。
- 转移风险升高的因素包括:80至89岁(HR 1.23;95%CI 1.07-1.43)、90岁及以上(HR 1.35;95%CI 1.09-1.66)、男性(HR 1.79;95%CI 1.52-2.10)、免疫抑制(HR 1.99;95%CI 1.64-2.42)、最高贫困五分位(HR 1.64;95%CI 1.35-2.00)。
- 原发肿瘤位于耳部(HR 1.70;95%CI 1.42-2.03)和唇部(HR 1.85;95%CI 1.29-2.63)的转移风险最高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer with metastatic potential, but epidemiologic data are poor. Changes to the National Cancer Registration and Analysis Service (NCRAS) in England have allowed more accurate data analysis of primary and metastatic cSCC since 2013. OBJECTIVE: To assess the national incidence of cSCC and metastatic cSCC (mcSCC) in England from 2013 through 2015. DESIGN, SETTING, AND PARTICIPANTS: This national population-based study identified a cohort of patients with cSCC and mcSCC in England from January 1, 2013, through December 31, 2015. Patients were identified using diagnostic codes derived from pathology reports in the NCRAS. Data were analyzed from March 1, 2017, through March 1, 2018. MAIN OUTCOMES AND MEASURES: Incidence rates across sex and risk factors for cSCC were derived from the NCRAS data. Risk of occurrence of mcSCC among the population with cSCC was assessed with Cox proportional hazards regression analysis to determine indicators of mcSCC. RESULTS: Among the 76 977 patients with first primary cSCC in 2013 through 2015 (62.7% male; median age, 80 years [interquartile range, 72-86 years]), the age-standardized rates for the first registered cSCC in England from 2013 through 2015 were 77.3 per 100 000 person-years (PY) (95% CI, 76.6-78.0) in male patients and 34.1 per 100 000 PY (95% CI, 33.7-34.5) in female patients. Increased primary cSCC tumor count was observed in older, white male patients in lower deprivation quintiles. After a maximum follow-up of 36 months, cumulative incidence of mcSCC developed in 1.1% of women and 2.4% of men with a primary cSCC. Significant increases in the risk of metastasis with adjusted hazard rates of approximately 2.00 were observed in patients who were aged 80 to 89 years (hazard ratio [HR], 1.23; 95% CI, 1.07-1.43), 90 years or older (HR, 1.35; 95% CI, 1.09-1.66), male (HR, 1.79; 95% CI, 1.52-2.10), immunosuppressed (HR, 1.99; 95% CI, 1.64-2.42), and in higher deprivation quintiles (HR for highest quintile, 1.64; 95% CI, 1.35-2.00). Primary cSCC located on the ear (HR, 1.70; 95% CI, 1.42-2.03) and lip (HR, 1.85; 95% CI, 1.29-2.63) were at highest risk of metastasis. CONCLUSIONS AND RELEVANCE: This study presents the first national study of the incidence of mcSCC. With limited health care resources and an aging population, accurate epidemiologic data are essential for informing future health care planning, identifying high-risk patients, and evaluating skin cancer prevention policies.
引用
- Venables ZC, Autier P, Nijsten T, et al. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England. JAMA Dermatol. 2019. PMID: 30484823. doi:10.1001/jamadermatol.2018.4219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。